Vista Pharmaceuticals Ltd (524711):企業の財務・戦略的SWOT分析

◆英語タイトル:Vista Pharmaceuticals Ltd (524711) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15150
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vista Pharmaceuticals Ltd (Vista), a subsidiary of Torrent Pharmaceuticals Ltd, is a pharmaceutical company that offers over the counter and prescription generic products. The company offers drugs in the form of tablets, capsules and liquids for various therapeutic areas. It offers products such as sulfamethoxazole and trimethoprim, isoxsuprine HCL, sulfamethoxazole and trimethoprim, bismuth subsalicylate, bismuth subgallate and pyrantel pamoate, among others. Vista also offers aspirin, atenolol, cotrimoxazole, chloroquine phosphate, captopril, carbamazipine, frusemide, glibenclamide, ibuprofen, methyldopa, mebendazole, metronidazole, nefidipine, paracetamol, pyrimethamine and sulfadiazine, among others. The company has operations in India and the US. Vista is headquartered in Hyderabad, Telangana, India.

Vista Pharmaceuticals Ltd Key Recent Developments

Feb 24,2018: Vista Pharmaceuticals Announces Board Changes
Feb 10,2018: vista Pharmaceuticals had an USFDA Inspection and issued with Observations

This comprehensive SWOT profile of Vista Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vista Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Vista Pharmaceuticals Ltd – Key Information
Vista Pharmaceuticals Ltd – Overview
Vista Pharmaceuticals Ltd – Key Employees
Vista Pharmaceuticals Ltd – Key Employee Biographies
Vista Pharmaceuticals Ltd – Key Operational Heads
Vista Pharmaceuticals Ltd – Major Products and Services
Vista Pharmaceuticals Ltd – History
Vista Pharmaceuticals Ltd – Company Statement
Vista Pharmaceuticals Ltd – Locations And Subsidiaries
Vista Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Vista Pharmaceuticals Ltd – Business Description
Vista Pharmaceuticals Ltd – Corporate Strategy
Vista Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Vista Pharmaceuticals Ltd – Strengths
Vista Pharmaceuticals Ltd – Weaknesses
Vista Pharmaceuticals Ltd – Opportunities
Vista Pharmaceuticals Ltd – Threats
Vista Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Vista Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Vista Pharmaceuticals Ltd, Key Information
Vista Pharmaceuticals Ltd, Key Ratios
Vista Pharmaceuticals Ltd, Share Data
Vista Pharmaceuticals Ltd, Major Products and Services
Vista Pharmaceuticals Ltd, History
Vista Pharmaceuticals Ltd, Key Employees
Vista Pharmaceuticals Ltd, Key Employee Biographies
Vista Pharmaceuticals Ltd, Key Operational Heads
Vista Pharmaceuticals Ltd, Other Locations
Vista Pharmaceuticals Ltd, Subsidiaries
Vista Pharmaceuticals Ltd, Key Manufacturing facilities
Vista Pharmaceuticals Ltd, Key Competitors
Vista Pharmaceuticals Ltd, SWOT Analysis
Vista Pharmaceuticals Ltd, Ratios based on current share price
Vista Pharmaceuticals Ltd, Annual Ratios
Vista Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Vista Pharmaceuticals Ltd, Performance Chart
Vista Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Vista Pharmaceuticals Ltd (524711):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in tra …
  • Esso (Thailand) Public Company Ltd (ESSO):企業の財務・戦略的SWOT分析
    Esso (Thailand) Public Company Ltd (ESSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Toho Holdings Co Ltd (8129):企業の財務・戦略的SWOT分析
    Toho Holdings Co Ltd (8129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sino Land Co Ltd:企業の戦略・SWOT・財務情報
    Sino Land Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sino Land Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Westinghouse Air Brake Technologies Corporation:企業のM&A・事業提携・投資動向
    Westinghouse Air Brake Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westinghouse Air Brake Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Natera Inc (NTRA):企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers Panorama, a non-invasive prenatal screening test that analyzes baby's DNA through a simple blood dra …
  • Lamprell Plc (LAM):石油・ガス:M&Aディール及び事業提携情報
    Summary Lamprell Plc (Lamprell) is an oil and gas company that provides offshore industry services. The company's business activities comprise construction of new build jackup drilling rigs, construction projects for the offshore oil and gas industry, engineering and construction, renewable and mult …
  • Acutus Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acutus Medical Inc (Acutus Medical) engaged in providing electrophysiological mapping systems for the treatment of cardiac arrhythmias. The company offers various products which include AcQMap system, AcQMap 3D imaging and mapping catheter; and AcQGuide steerable sheath. Acutus Medical’s ele …
  • Botswana Power Corporation:発電所・企業SWOT分析
    Botswana Power Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • MedinCell SA (MEDCL):製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Ironwood Pharmaceuticals Inc (IRWD):企業の財務・戦略的SWOT分析
    Ironwood Pharmaceuticals Inc (IRWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Canacol Energy Ltd (CNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canacol Energy Ltd (Canacol Energy) is an oil and gas company that explores and produces conventional and unconventional oil fields. The company operates oil and gas reserves in Caguan-Putumayo basin, Lower Magdalena basin, Llanos basin, Magdalena basin in Colombia; and Oriente basin in Ecua …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • The Hokuetsu Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Achaogen Inc (AKAO):製薬・医療:M&Aディール及び事業提携情報
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company offers plazomicin for the treatment of serious bacterial infections including urinary t …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • SenesTech Inc (SNES):企業の財務・戦略的SWOT分析
    SenesTech Inc (SNES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Immatics Biotechnologies GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Immatics Biotechnologies GmbH (Immatics) is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆